344
Views
43
CrossRef citations to date
0
Altmetric
Morbidity

Mortality Risk Among Recent-Onset Injection Drug Users in Five U.S. Cities

, , , , , , , & show all
Pages 413-428 | Published online: 03 Jul 2009

References

  • Bargagli A. M., Sperati A., Davoli M., Forastiere F., Perucci C. A. Mortality among problem drug users in Rome: An 18-year follow-up study, 1980–97. Addiction 2001; 96(10)1455–1463
  • Bird S. M., Hutchinson S. J., Goldberg D. J. Drug-related deaths by region, sex, and age group per 100 injecting drug users in Scotland, 2000–01. Lancet 2003; 362(9388)941–944
  • Brookmeyer R., Gail M. H. Biases in prevalent cohorts. Biometrics 1987; 43(4)739–749
  • Chitwood D. D., Comerford M., Kitner K. R., Palacios W., Sanchez J. A comparison of HIV risk behaviors between new and long-term injection drug users. Substance Use & Misuse 2001; 36(1–2)91–111
  • Egger M., May M., Chene G., Phillips A. N., Ledergerber B., Dabis F. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. Lancet 2002; 360(9327)119–129
  • Garfein R. S., Vlahov D., Galai N., Doherty M. C., Nelson K. E. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health 1996; 86(5)655–661
  • Goedert J. J., Fung M. W., Felton S., Battjes R. J., Engels E. A. Cause-specific mortality associated with HIV and HTLV-II infections among injecting drug users in the USA. AIDS 2001; 15(10)1295–1302
  • Kallen J. E. Drug abuse related mortality in the United States: Patterns and correlates. The American Journal of Drug and Alcohol Abuse 1998; 24: 103–117
  • Latka M., Ahern J., Garfein R. S., Ouellet L., Kerndt P., Morse P., et al. Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. Journal of Substance Abuse 2001; 13(1–2)73–88
  • Messeri P., Lee G., Abramson D. M., Aidala A., Chiasson M. A., Jessop D. J. Antiretroviral therapy and declining AIDS mortality in New York City. Medical Care 2003; 41(4)512–521
  • Nicolosi A., Leite M. L., Molinari S., Musicco M., Saracco A., Lazzarin A. Incidence and prevalence trends of HIV infection in intravenous drug users attending treatment centers in Milan and northern Italy, 1986–1990. Journal of Acquired Immune Deficiency Syndromes 1992; 5(4)365–373
  • O'Brien C. S., Crandall C. S., McKinney P. E. From poppy fields to Potter's Field: Increased mortality after nonfatal heroin overdose. Academic Emergency Medicine 2003; 10(5)535–536
  • Perucci C. A., Davoli M., Rapiti E., Abeni D. D., Forastiere F. Mortality of intravenous drug users in Rome: A cohort study. American Journal of Public Health 1991; 81: 1307–1310
  • Seal K. H., Thawley R., Gee L., Bamberger J., Kral A. H., Ciccarone D., et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study. Journal of Urban Health 2005; 82(2)303–311
  • Sorlie P. D., Backlund E., Keller J. B. US mortality by economic, demographic and social characteristics: The national longitudinal mortality study. American Journal of Public Health 1995; 85: 949–956
  • Vlahov D., Wang C. L., Galai N., Bareta J., Mehta S. H., Strathdee S. A., et al. Mortality risk among new onset injection drug users. Addiction 2004; 99: 946–954

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.